MD vs EHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

MD

32.1
AI Score
VS
EHC Wins

EHC

33.8
AI Score

Investment Advisor Scores

MD

32score
Recommendation
AVOID NEW MONEY

EHC

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric MD EHC Winner
Forward P/E 9.2937 19.1205 MD
PEG Ratio 0.2433 0.4094 MD
Revenue Growth 1.7% 8.9% EHC
Earnings Growth -29.8% 21.6% EHC
Tradestie Score 32.1/100 33.8/100 EHC
Profit Margin 7.7% 10.2% EHC
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED EHC

Relative Price Performance (Last 90 Days)

MD 1M: +17.5% · 3M: +19.3% EHC 1M: +14.5% · 3M: +14.2%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 68

RSI (14): 68.3 · Price: $31.62

EHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 69

RSI (14): 68.8 · Price: $142.51

Fundamentals Snapshot

Metric MD EHC
Market Cap — —
Forward P/E 12.8 20.7
Trailing P/E 17.2 22.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.2%
EPS 1.83 6.25
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, EHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.